CRYOPORT, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
CRYOPORT, INC. (CYRX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 9.57 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- CRYOPORT, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 9.57M shares, a 0.80% increase year-over-year.
- CRYOPORT, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 8.95M shares, a 2.68% decline year-over-year.
- CRYOPORT, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 8.71M shares, a 7.29% decline year-over-year.
- CRYOPORT, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 9.50M shares, a 25.23% decline year-over-year.
- CRYOPORT, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 8.80M shares, a 11.31% decline from fiscal 2024.
- CRYOPORT, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 9.93M shares, a 19.00% decline from fiscal 2023.
- CRYOPORT, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 12.25M shares, a 16.12% decline from fiscal 2022.
- CRYOPORT, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 14.61M shares, a 4.45% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 9.57M shares 10-Q · filed 2026-08-06 | 9.28M shares 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | 8.95M shares 10-Q · filed 2026-05-05 | |||||||
| 2025-12-31 | 8.80M shares 10-K · filed 2026-03-05 | |||||||
| 2025-09-30 | 8.71M shares 10-Q · filed 2025-11-06 | 8.70M shares 10-Q · filed 2025-11-06 | ||||||
| 2025-06-30 | 9.50M shares 10-Q · filed 2026-08-06 | 9.53M shares 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | 9.20M shares 10-Q · filed 2026-05-05 | 10.40M shares 10-Q · filed 2025-05-08 | ||||||
| 2024-12-31 | 9.93M shares 10-K · filed 2026-03-05 | 10.49M shares 10-K · filed 2025-03-07 | ||||||
| 2024-09-30 | 9.39M shares 10-Q · filed 2025-11-06 | 9.35M shares 10-Q · filed 2024-11-07 | 10.06M shares 10-Q · filed 2025-11-06 | 10.43M shares 10-Q · filed 2024-11-07 | ||||
| 2024-06-30 | 12.70M shares 10-Q · filed 2025-08-12 | 12.37M shares 10-Q · filed 2025-08-12 | ||||||
| 2024-03-31 | 13.12M shares 10-Q · filed 2025-05-08 | |||||||
| 2023-12-31 | 12.25M shares 10-K · filed 2026-03-05 | 13.21M shares 10-K · filed 2024-03-13 | ||||||
| 2023-09-30 | 12.82M shares 10-Q · filed 2024-11-07 | 13.40M shares 10-Q · filed 2024-11-07 | ||||||
| 2023-06-30 | 13.91M shares 10-Q · filed 2024-08-08 | 13.99M shares 10-Q · filed 2024-08-08 | ||||||
| 2023-03-31 | 13.85M shares 10-Q · filed 2024-05-08 | 13.85B shares 10-Q · filed 2023-05-04 | ||||||
| 2022-12-31 | 14.61M shares 10-K · filed 2025-03-07 | |||||||
| 2022-09-30 | 14.86M shares 10-Q · filed 2023-11-09 | 14.77M shares 10-Q · filed 2023-11-09 | ||||||
| 2022-06-30 | 13.74M shares 10-Q · filed 2023-08-09 | 14.13M shares 10-Q · filed 2023-08-09 | ||||||
| 2022-03-31 | 14.91B shares 10-Q · filed 2023-05-04 | 14.91M shares 10-Q · filed 2022-05-05 | ||||||
| 2021-12-31 | 15.29M shares 10-K · filed 2024-03-13 | |||||||
| 2021-09-30 | 16.18M shares 10-Q · filed 2022-11-04 | 16.13M shares 10-Q · filed 2022-11-04 | ||||||
| 2021-06-30 | 16.29M shares 10-Q · filed 2022-08-04 | 16.34M shares 10-Q · filed 2022-08-04 | ||||||
| 2021-03-31 | 16.55M shares 10-Q · filed 2022-05-05 | |||||||
| 2020-12-31 | 17.21M shares 10-K · filed 2023-02-28 | |||||||
| 2020-09-30 | 10.63M shares 10-Q · filed 2021-11-04 | 9.74M shares 10-Q · filed 2021-11-04 | ||||||
| 2020-06-30 | 9.54M shares 10-Q · filed 2021-08-06 | 9.16M shares 10-Q · filed 2021-08-06 | ||||||
| 2020-03-31 | 4.37M shares 10-Q · filed 2021-05-06 | |||||||
| 2019-12-31 | 4.39M shares 10-K · filed 2022-02-28 | |||||||
| 2019-09-30 | 6.51M shares 10-Q · filed 2020-11-06 | 5.84M shares 10-Q · filed 2020-11-06 | ||||||
| 2019-06-30 | 6.36M shares 10-Q · filed 2020-08-10 | 5.81M shares 10-Q · filed 2020-08-10 | ||||||
| 2019-03-31 | 5.52M shares 10-Q · filed 2020-05-08 | |||||||
| 2018-12-31 | 5.83M shares 10-K · filed 2020-03-10 | |||||||
| 2018-09-30 | 7.33M shares 10-Q · filed 2019-11-12 | 7.07M shares 10-Q · filed 2019-11-12 | ||||||
| 2018-06-30 | 4.77M shares 10-Q · filed 2019-08-09 | 4.45M shares 10-Q · filed 2019-08-09 | 4.45M shares 10-Q · filed 2018-08-09 | |||||
| 2018-03-31 | 6.02M shares 10-Q · filed 2019-05-09 | |||||||
| 2017-12-31 | 9.16M shares 10-K · filed 2019-03-13 | |||||||
| 2017-09-30 | 5.12M shares 10-Q · filed 2018-11-08 | 6.19M shares 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | 1.38M shares 10-Q · filed 2018-08-09 | 1.39M shares 10-Q · filed 2018-08-09 | ||||||
| 2017-03-31 | 675.68K shares 10-Q · filed 2018-05-03 | |||||||
| 2016-12-31 | 165.19K shares 10-K · filed 2018-03-08 | |||||||
| 2016-09-30 | 103.47K shares 10-Q · filed 2016-11-14 | 603.53K shares 10-Q · filed 2017-11-02 | ||||||
| 2016-06-30 | 110.58K shares 10-Q · filed 2016-08-15 | 2.55M shares 10-Q · filed 2017-08-09 | ||||||
| 2016-03-31 | 54.71K shares 10-Q · filed 2017-05-04 | 1.18M shares 10-KT · filed 2017-03-13 | ||||||
| 2015-12-31 | 3.94M shares 10-Q · filed 2016-02-11 | |||||||
| 2015-09-30 | 4.19M shares 10-Q · filed 2016-11-14 | |||||||
| 2015-06-30 | 4.35M shares 10-Q · filed 2016-08-15 | |||||||
| 2015-03-31 | 2.40M shares 10-K · filed 2016-06-28 | |||||||
| 2014-12-31 | 1.89M shares 10-Q · filed 2016-02-11 | 22.72M shares 10-Q · filed 2015-02-05 | ||||||
| 2014-09-30 | 1.60M shares 10-Q · filed 2015-11-16 | 19.22M shares 10-Q · filed 2014-11-12 | ||||||
| 2014-06-30 | 774.50K shares 10-Q · filed 2015-08-06 | 9.29M shares 10-Q · filed 2014-07-31 | ||||||
| 2014-03-31 | 556.67K shares 10-K · filed 2015-05-19 | 6.68M shares 10-K · filed 2014-06-25 | ||||||
| 2013-12-31 | 34.05M shares 10-Q · filed 2015-02-05 | |||||||
| 2013-09-30 | 13.96M shares 10-Q · filed 2014-11-12 | |||||||
| 2013-06-30 | 971.17K shares 10-Q · filed 2014-07-31 | |||||||
| 2013-03-31 | 411.76K shares 10-K · filed 2014-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |